Finding the Cause: Your Diagnostic Roadmap
At a Glance
When hair loss occurs with antibody deficiency, testing examines immune function, the scalp and hair follicles, adrenal and parathyroid hormones, and genes such as NFKB2, AIRE, and FOXN1. Specialists use the results to distinguish CVID from rare genetic syndromes.
When you have both hair loss and an immune system that doesn’t make enough antibodies, the diagnostic process is like a detective story. Because this combination is rare, your medical team needs to look at three different “scenes” at once: your immune system, your skin, and your hormone-producing glands.
This multidisciplinary approach is the only way to tell if you have a common co-occurrence (like CVID) or a rare genetic syndrome (like NFKB2 deficiency or APECED).
Branch 1: The Immunology Workup
The first goal is to confirm if your antibody deficiency is persistent and functional, after ruling out secondary causes (like protein loss, medications, or HIV). Your immunologist will typically order:
- Quantitative Immunoglobulins: A blood test to measure the total amount of IgG, IgA, and IgM in your system. This is usually repeated to ensure age-appropriate ranges [1].
- Vaccine Response Testing: This must be planned and interpreted by an immunologist. You receive a vaccine and have your blood checked later to see if your body successfully built protective antibodies. (Caveat: Immunoglobulin replacement can confound results, and vaccination may be unsafe in suspected significant T-cell deficiency) [2][3].
- Flow Cytometry (Lymphocyte Subsets): This detailed test counts your different types of white blood cells. Doctors look specifically for switched-memory B-cells. If these are reduced, it can support a CVID phenotype, though it is not required nor specific [4][5].
- T-cell Function: If a more severe syndrome is suspected, they may test how well your T-cells multiply when they encounter a trigger [6].
Branch 2: The Dermatology Workup
The dermatologist’s job is to determine the exact “flavor” of your hair loss. (A negative genetic panel does not establish CVID, and alternative diagnoses like tinea, telogen effluvium, or androgenetic hair loss must be excluded).
- Clinical Exam & Pull Test: The doctor will examine the pattern of hair loss (patchy vs. total) and gently tug on hairs to see if they are in an active shedding phase [7].
- Trichoscopy: Using a specialized magnifying tool, the doctor looks for specific shapes, such as exclamation mark hairs (common in Alopecia Areata) or black dots [8][9].
- Scalp Biopsy: If the diagnosis is unclear, a 4-mm “punch” biopsy of the scalp may be performed. This allows a pathologist to look at the hair follicles under a microscope to check for inflammation or scarring [10][11].
Branch 3: The Endocrine & Genetic Workup
This branch is vital for safety, as it looks for “hidden” hormone problems that often accompany rare genetic hair loss syndromes.
- Adrenal Screening: Testing morning cortisol and ACTH levels can be evaluated if NFKB2 deficiency is suspected [12]. Because a morning cortisol can be indeterminate, an endocrinologist may need dynamic testing or longitudinal surveillance. If these are low, you may need an ACTH stimulation test to see if your adrenal glands can respond to stress [13].
- Calcium & PTH: Low calcium or low parathyroid hormone can be a major clue for APECED [14][15].
- Anti-Interferon Antibodies: A specialized blood test for anti-type-I-interferon antibodies can help identify APECED [16].
- Targeted Genetic Panels: Finally, your team may use a “next-generation sequencing” panel to look for specific glitches in genes like NFKB2, AIRE, or FOXN1 [17][18]. (Note: Genetic testing may yield variants of uncertain significance and should ideally involve genetic counseling.)
Coordinating Your Care
Because these tests span so many specialties, it is easy for information to get lost. Patients with this clinical picture are best served by a multidisciplinary team where the immunologist, dermatologist, and endocrinologist share notes [19]. This ensures that while you are treating the hair loss (which is visible), you are not overlooking the antibody or hormone issues (which are invisible but potentially life-threatening).
Common questions in this guide
How do doctors confirm an antibody deficiency when I also have hair loss?
What tests determine the type of alopecia?
Why are adrenal and calcium tests part of this workup?
Can genetic testing explain hair loss and antibody deficiency?
Is a vaccine challenge safe and useful if I have low antibodies?
Why do I need several specialists for hair loss with antibody deficiency?
One line in your results can change your plan.
If NFKB2 deficiency is suspected, low morning cortisol or ACTH results may lead to an ACTH stimulation test. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Alopecia antibody deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Antibody deficiency testing for primary immunodeficiency: A practical review for the clinician.
Marsh RA, Orange JS
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(5)):444-453 doi:10.1016/j.anai.2019.08.012.
PMID: 31446132 - 2
Primary Immunodeficiency: Specific antibody deficiency with normal IgG.
Hatcher VR, Alix VC, Hellu TS, Schuldt MM
Allergy and asthma proceedings 2024; (45(5)):321-325 doi:10.2500/aap.2024.45.240057.
PMID: 39294904 - 3
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders.
Ameratunga R, Longhurst H, Leung E, et al.
Clinical immunology (Orlando, Fla.) 2024; (266()):110320 doi:10.1016/j.clim.2024.110320.
PMID: 39025346 - 4
EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.
van Dongen JJM, van der Burg M, Kalina T, et al.
Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.
PMID: 31263462 - 5
Current concepts: Common variable immunodeficiency.
Cunningham-Rundles C
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2026; (136(4)):376-386 doi:10.1016/j.anai.2025.11.009.
PMID: 41274495 - 6
Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2.
Klemann C, Camacho-Ordonez N, Yang L, et al.
Frontiers in immunology 2019; (10()):297 doi:10.3389/fimmu.2019.00297.
PMID: 30941118 - 7
- 8
Trichoscopy of alopecia areata: An update.
Waśkiel A, Rakowska A, Sikora M, et al.
The Journal of dermatology 2018; (45(6)):692-700 doi:10.1111/1346-8138.14283.
PMID: 29569271 - 9
Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
Zhang X, Ye Y, Zhu Z, et al.
Experimental dermatology 2020; (29(3)):223-230 doi:10.1111/exd.13799.
PMID: 30307062 - 10
Scalp Biopsies for Alopecia.
Brunetti T, Misciali C, Rapparini L, et al.
Dermatopathology (Basel, Switzerland) 2026; (13(3)) doi:10.3390/dermatopathology13030044.
PMID: 42782841 - 11
Alopecia areata.
Pratt CH, King LE, Messenger AG, et al.
Nature reviews. Disease primers 2017; (3()):17011 doi:10.1038/nrdp.2017.11.
PMID: 28300084 - 12
Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports.
Mac TT, Castinetti F, Bar C, et al.
Journal of neuroendocrinology 2023; (35(6)):e13287 doi:10.1111/jne.13287.
PMID: 37322808 - 13
Symptomatic hypoglycemia in a child with common variable immunodeficiency: Deficient anterior pituitary with variable immune deficiency (DAVID) syndrome.
Nogueira M, Pinheiro M, Maia R, et al.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2020; (29(3)):111-113 doi:10.1297/cpe.29.111.
PMID: 32694887 - 14
Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G, Pivin M, Hangan T, et al.
Autoimmunity reviews 2022; (21(8)):103135 doi:10.1016/j.autrev.2022.103135.
PMID: 35690244 - 15
Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review.
Sandru F, Petca RC, Dumitrascu MC, et al.
Biomedicines 2024; (12(1)) doi:10.3390/biomedicines12010132.
PMID: 38255237 - 16
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Ferre EM, Rose SR, Rosenzweig SD, et al.
JCI insight 2016; (1(13)).
PMID: 27588307 - 17
The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like Disorders.
Ameratunga R, Edwards ESJ, Lehnert K, et al.
The journal of allergy and clinical immunology. In practice 2023; (11(6)):1646-1664 doi:10.1016/j.jaip.2023.01.048.
PMID: 36796510 - 18
Perspective: Application of the American College of Medical Genetics Variant Interpretation Criteria to Common Variable Immunodeficiency Disorders.
Ameratunga R, Allan C, Lehnert K, Woon ST
Clinical reviews in allergy & immunology 2021; (61(2)):226-235 doi:10.1007/s12016-020-08828-z.
PMID: 33818703 - 19
Common Variable Immunodeficiency Disorders: A perspective from New Zealand.
Ameratunga R, J Longhurst H, Lehnert K, et al.
Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.
PMID: 41324804
This diagnostic roadmap is for informational purposes only and does not constitute medical advice. Your immunologist, dermatologist, endocrinologist, and genetic counselor should interpret your results and decide which tests are appropriate and safe.